Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
National Cancer Institute (NCI)
California Breast Cancer Research Program
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT01219075
First received: October 7, 2010
Last updated: April 6, 2016
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):